Carvedilol Attenuates 6-Hydroxydopamine-Induced Cell Death in PC12 Cells: Involvement of Akt and Nrf2/ARE Pathways

Neurochemical Research

Volumn 39, Issue 9, 2014, Pages 1733-1740

  Wang, Lan ^a   Wang, Rikang ^b   Jin, Minghua ^b   Huang, Yingjuan ^b   Liu, Anmin ^b   Qin, Jian ^b   Chen, Meihui ^b   Wen, Shijun ^b   Pi, Rongbiao ^b   Shen, Wei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

6 Hydroxydopamine; Akt; Carvedilol; Heme oxygenase 1; Nuclear factor E2 related factor 2

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; CARVEDILOL; NFE2L2 PROTEIN, RAT; OXIDOPAMINE; PROPANOLAMINE DERIVATIVE; PROTEIN KINASE B; TRANSCRIPTION FACTOR NRF2;

ANIMAL; CELL DEATH; DRUG EFFECTS; METABOLISM; PC12 CELL LINE; RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARBAZOLES; CELL DEATH; NF-E2-RELATED FACTOR 2; OXIDOPAMINE; PC12 CELLS; PROPANOLAMINES; PROTO-ONCOGENE PROTEINS C-AKT; RATS;

EID: 84939894176     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-014-1367-2     Document Type: Article

References (31)

1. Gaki GS, Papavassiliou AG (2014) Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson’s disease. Neuromol Med 16(2):217–230
2. Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death. Neurobiol Aging 23(5):655–664
3. 2 release at NADH: ubiquinone oxidoreductase (Complex I) in brain mitochondria. Biochem J 406(1):125–129
4. Massaad CA (2011) Neuronal and vascular oxidative stress in Alzheimer’s disease. Curr Neuropharmacol 9(4):662–673
5. Poon HF, Calabrese V, Scapagnini G, Butterfield DA (2004) Free radicals and brain aging. Clin Geriatr Med 20(2):329–359
6. Blandini F, Armentero MT, Martignoni E (2008) The 6-hydroxydopamine model: news from the past. Parkinsonism Relat Disord 14(Suppl 2):S124–S129
7. Simola N, Morelli M, Carta AR (2007) The 6-hydroxydopamine model of Parkinson’s disease. Neurotox Res 11(3–4):151–167
8. Paradies G, Petrosillo G, Paradies V, Ruggiero FM (2011) Mitochondrial dysfunction in brain aging: role of oxidative stress and cardiolipin. Neurochem Int 58(4):447–457
9. Chen G, Bower KA, Ma C, Fang S, Thiele CJ, Luo J (2004) Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB J 18(10):1162–1164
10. Camins A, Verdaguer E, Junyent F, Yeste-Velasco M, Pelegri C, Vilaplana J, Pallas M (2009) Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium. CNS Neurosci Ther 15(4):333–344
11. Quiroz JA, Machado-Vieira R, Zarate CA Jr, Manji HK (2010) Novel insights into lithium’s mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 62(1):50–60
12. Zheng L, Ishii Y, Tokunaga A, Hamashima T, Shen J, Zhao QL, Ishizawa S, Fujimori T, Nabeshima Y, Mori H, Kondo T, Sasahara M (2010) Neuroprotective effects of PDGF against oxidative stress and the signaling pathway involved. J Neurosci Res 88(6):1273–1284
13. Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, Williamson TP, Kraft AD, Lee JM, Li J, Johnson JA (2009) The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal 11(3):497–508
14. van Muiswinkel FL, Kuiperij HB (2005) The Nrf2-ARE signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders. Curr Drug Targets CNS Neurol Disord 4(3):267–281
15. Savitz SI, Erhardt JA, Anthony JV, Gupta G, Li X, Barone FC, Rosenbaum DM (2000) The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab 20(8):1197–1204
16. Yaoita H, Sakabe A, Maehara K, Maruyama Y (2002) Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Circulation 105(8):975–980
17. Abreu RM, Santos DJ, Moreno AJ (2000) Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress. J Pharmacol Exp Ther 295(3):1022–1030
18. Lysko PG, Lysko KA, Yue TL, Webb CL, Gu JL, Feuerstein G (1992) Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke 23 (11):1630–1635; discussion 1635–1636
19. Kumar A, Prakash A, Dogra S (2011) Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats. Pharmacol Rep 63(4):915–923
20. Yoshioka T, Iwamoto N, Tsukahara F, Irie K, Urakawa I, Muraki T (2000) Anti-NO action of carvedilol in cell-free system and in vascular endothelial cells. Br J Pharmacol 129(7):1530–1535
21. Macedo B, Magalhaes J, Batista AR, Saraiva MJ (2010) Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacol Res 62(6):514–522
22. Oettl K, Greilberger J, Zangger K, Haslinger E, Reibnegger G, Jurgens G (2001) Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity. Biochem Pharmacol 62(2):241–248
23. Ouyang Y, Chen Z, Tan M, Liu A, Chen M, Liu J, Pi R, Fang J (2013) Carvedilol, a third-generation beta-blocker prevents oxidative stress-induced neuronal death and activates Nrf2/ARE pathway in HT22 cells. Biochem Biophys Res Commun 441(4):917–922
24. Bang SY, Kim JH, Kim HY, Lee YJ, Park SY, Lee SJ, Kim Y (2012) Achyranthes japonica exhibits anti-inflammatory effect via NF-kappaB suppression and HO-1 induction in macrophages. J Ethnopharmacol 144(1):109–117
25. Zhang H, Mak S, Cui W, Li W, Han R, Hu S, Ye M, Pi R, Han Y (2011) Tacrine (2)-ferulic acid, a novel multifunctional dimer, attenuates 6-hydroxydopamine-induced apoptosis in PC12 cells by activating Akt pathway. Neurochem Int 59(7):981–988
26. Brubacher JL, Bols NC (2001) Chemically de-acetylated 2’,7’-dichlorodihydrofluorescein diacetate as a probe of respiratory burst activity in mononuclear phagocytes. J Immunol Methods 251(1–2):81–91
27. Jomova K, Vondrakova D, Lawson M, Valko M (2010) Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345(1–2):91–104
28. Carreira RS, Monteiro P, Gon Alves LM, Providencia LA (2006) Carvedilol: just another beta-blocker or a powerful cardioprotector? Cardiovasc Hematol Disord Drug Targets 6(4):257–266
29. Li W, Yu SW, Kong AN (2006) Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain. J Biol Chem 281(37):27251–27263
30. Itoh K, Tong KI, Yamamoto M (2004) Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 36(10):1208–1213
31. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME (1997) Regulation of neuronal survival by the serine–threonine protein kinase Akt. Science 275(5300):661–665